Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma
- Role of MRI in Primary Brain Tumor Evaluation
- Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications
- Changes in Serial Magnetic Resonance Spectroscopy Predict Outcome in High-grade Glioma During and After Postoperative Radiotherapy
- Permeability Estimates in Histopathology-Proved Treatment-Induced Necrosis Using Perfusion CT: Can These Add to Other Perfusion Parameters in Differentiating from Recurrent/Progressive Tumors?
- Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging
- The Extent and Severity of Vascular Leakage as Evidence of Tumor Aggressiveness in High-Grade Gliomas
- Diagnosis and Treatment of Recurrent High-Grade Astrocytoma
- Physiologic and Metabolic Magnetic Resonance Imaging in Gliomas
- NMR Spectroscopy and Pediatric Brain Tumors